- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Cora Health Expands Telehealth Access to GLP-1 Medications Across 44 States
Telehealth platform offers compounded semaglutide and tirzepatide through licensed providers with free shipping
Apr. 14, 2026 at 12:34am
Got story updates? Submit your updates here. ›
Compounded GLP-1 medications offer a more affordable path to weight loss treatments for patients without adequate insurance coverage.NYC TodayCora Health, a US-based telehealth company, has launched a provider-guided treatment platform offering compounded GLP-1 receptor agonist medications to patients in 44 states. The platform pairs patients with board-certified providers and ships medications directly from a US-licensed compounding pharmacy, addressing the access gap for these high-cost brand-name medications.
Why it matters
GLP-1 receptor agonists have shown significant weight loss benefits in clinical trials, but the high list prices of brand-name versions have limited access for many patients. Cora Health's telehealth model aims to make these medications more affordable and accessible through compounded formulations prescribed by licensed providers.
The details
Cora Health's platform connects patients with licensed providers who prescribe compounded semaglutide and tirzepatide prepared by 503A state-licensed pharmacies. Plans start at $120 per month and include the provider consultation, pharmacy fulfillment, and free expedited shipping. The company is LegitScript certified and fully HIPAA compliant, with its pharmacy partner operating in compliance with FDA and USP guidelines.
- Cora Health launched its telehealth platform in 2026.
- The company has provided care to over 7,000 patients since launch.
The players
Cora Health
A US-based telehealth company that connects patients with licensed healthcare providers for personalized GLP-1 treatment plans.
Wasef Health, PC
An independent medical practice that employs the prescribing providers for Cora Health's platform and makes all treatment decisions based on individual clinical evaluation.
VialsRx
Cora Health's pharmacy partner that operates in compliance with FDA guidelines and USP sterile compounding standards to prepare the compounded GLP-1 medications.
What’s next
Cora Health plans to continue expanding its telehealth platform to additional states, providing more patients with affordable access to compounded GLP-1 medications.
The takeaway
Cora Health's telehealth model addresses the high cost barrier for brand-name GLP-1 medications, offering patients a more accessible and affordable option through compounded formulations prescribed by licensed providers.
